| Product Code: ETC8718879 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Pakistan Pharmacogenetic Testing Market Overview |
3.1 Pakistan Country Macro Economic Indicators |
3.2 Pakistan Pharmacogenetic Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Pakistan Pharmacogenetic Testing Market - Industry Life Cycle |
3.4 Pakistan Pharmacogenetic Testing Market - Porter's Five Forces |
3.5 Pakistan Pharmacogenetic Testing Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Pakistan Pharmacogenetic Testing Market Revenues & Volume Share, By Gene Type, 2021 & 2031F |
3.7 Pakistan Pharmacogenetic Testing Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 Pakistan Pharmacogenetic Testing Market Revenues & Volume Share, By Sample, 2021 & 2031F |
3.9 Pakistan Pharmacogenetic Testing Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.10 Pakistan Pharmacogenetic Testing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.11 Pakistan Pharmacogenetic Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Pakistan Pharmacogenetic Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about personalized medicine and its benefits in Pakistan |
4.2.2 Rising prevalence of chronic diseases requiring personalized treatment |
4.2.3 Growing investments in healthcare infrastructure and technology in Pakistan |
4.3 Market Restraints |
4.3.1 Limited availability of skilled professionals for conducting pharmacogenetic testing |
4.3.2 High cost associated with pharmacogenetic testing services |
4.3.3 Lack of standardized regulations and guidelines for pharmacogenetic testing in Pakistan |
5 Pakistan Pharmacogenetic Testing Market Trends |
6 Pakistan Pharmacogenetic Testing Market, By Types |
6.1 Pakistan Pharmacogenetic Testing Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Pakistan Pharmacogenetic Testing Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Pakistan Pharmacogenetic Testing Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 Pakistan Pharmacogenetic Testing Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.1.5 Pakistan Pharmacogenetic Testing Market Revenues & Volume, By Array-Based Tests, 2021- 2031F |
6.1.6 Pakistan Pharmacogenetic Testing Market Revenues & Volume, By Single Gene Tests, 2021- 2031F |
6.2 Pakistan Pharmacogenetic Testing Market, By Gene Type |
6.2.1 Overview and Analysis |
6.2.2 Pakistan Pharmacogenetic Testing Market Revenues & Volume, By CYP2C19, 2021- 2031F |
6.2.3 Pakistan Pharmacogenetic Testing Market Revenues & Volume, By CYP2D6, 2021- 2031F |
6.2.4 Pakistan Pharmacogenetic Testing Market Revenues & Volume, By CYP2C9 and VKORC1, 2021- 2031F |
6.2.5 Pakistan Pharmacogenetic Testing Market Revenues & Volume, By CYP1A2, 2021- 2031F |
6.2.6 Pakistan Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*1502, 2021- 2031F |
6.2.7 Pakistan Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*5701, 2021- 2031F |
6.3 Pakistan Pharmacogenetic Testing Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 Pakistan Pharmacogenetic Testing Market Revenues & Volume, By Prescription Drugs, 2021- 2031F |
6.3.3 Pakistan Pharmacogenetic Testing Market Revenues & Volume, By Nutraceuticals, 2021- 2031F |
6.3.4 Pakistan Pharmacogenetic Testing Market Revenues & Volume, By Recreational Drugs, 2021- 2031F |
6.3.5 Pakistan Pharmacogenetic Testing Market Revenues & Volume, By Herbal Supplements, 2021- 2031F |
6.3.6 Pakistan Pharmacogenetic Testing Market Revenues & Volume, By Vitamins, 2021- 2031F |
6.3.7 Pakistan Pharmacogenetic Testing Market Revenues & Volume, By Over-the-Counter Medications, 2021- 2031F |
6.4 Pakistan Pharmacogenetic Testing Market, By Sample |
6.4.1 Overview and Analysis |
6.4.2 Pakistan Pharmacogenetic Testing Market Revenues & Volume, By Blood, 2021- 2031F |
6.4.3 Pakistan Pharmacogenetic Testing Market Revenues & Volume, By Saliva, 2021- 2031F |
6.5 Pakistan Pharmacogenetic Testing Market, By Therapeutic Area |
6.5.1 Overview and Analysis |
6.5.2 Pakistan Pharmacogenetic Testing Market Revenues & Volume, By Cardiology, 2021- 2031F |
6.5.3 Pakistan Pharmacogenetic Testing Market Revenues & Volume, By Gastroenterology, 2021- 2031F |
6.5.4 Pakistan Pharmacogenetic Testing Market Revenues & Volume, By Anesthesiology, 2021- 2031F |
6.5.5 Pakistan Pharmacogenetic Testing Market Revenues & Volume, By Genomics, 2021- 2031F |
6.5.6 Pakistan Pharmacogenetic Testing Market Revenues & Volume, By Endocrinology, 2021- 2031F |
6.5.7 Pakistan Pharmacogenetic Testing Market Revenues & Volume, By Immunology & Hypersensitivity, 2021- 2031F |
6.5.8 Pakistan Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.5.9 Pakistan Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Pakistan Pharmacogenetic Testing Market, By Application |
6.6.1 Overview and Analysis |
6.6.2 Pakistan Pharmacogenetic Testing Market Revenues & Volume, By Clinical Practice, 2021- 2031F |
6.6.3 Pakistan Pharmacogenetic Testing Market Revenues & Volume, By Drug Development, 2021- 2031F |
6.6.4 Pakistan Pharmacogenetic Testing Market Revenues & Volume, By Drug Regulation, 2021- 2031F |
6.7 Pakistan Pharmacogenetic Testing Market, By End User |
6.7.1 Overview and Analysis |
6.7.2 Pakistan Pharmacogenetic Testing Market Revenues & Volume, By Healthcare Providers, 2021- 2031F |
6.7.3 Pakistan Pharmacogenetic Testing Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.7.4 Pakistan Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 Pakistan Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
7 Pakistan Pharmacogenetic Testing Market Import-Export Trade Statistics |
7.1 Pakistan Pharmacogenetic Testing Market Export to Major Countries |
7.2 Pakistan Pharmacogenetic Testing Market Imports from Major Countries |
8 Pakistan Pharmacogenetic Testing Market Key Performance Indicators |
8.1 Number of healthcare facilities offering pharmacogenetic testing services in Pakistan |
8.2 Adoption rate of pharmacogenetic testing by healthcare providers in Pakistan |
8.3 Research and development investments in pharmacogenetic testing technologies in Pakistan |
9 Pakistan Pharmacogenetic Testing Market - Opportunity Assessment |
9.1 Pakistan Pharmacogenetic Testing Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Pakistan Pharmacogenetic Testing Market Opportunity Assessment, By Gene Type, 2021 & 2031F |
9.3 Pakistan Pharmacogenetic Testing Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 Pakistan Pharmacogenetic Testing Market Opportunity Assessment, By Sample, 2021 & 2031F |
9.5 Pakistan Pharmacogenetic Testing Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
9.6 Pakistan Pharmacogenetic Testing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.7 Pakistan Pharmacogenetic Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Pakistan Pharmacogenetic Testing Market - Competitive Landscape |
10.1 Pakistan Pharmacogenetic Testing Market Revenue Share, By Companies, 2024 |
10.2 Pakistan Pharmacogenetic Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here